Vaccination of neonates: Problem and issues

Vaccine

Volumn 30, Issue 9, 2012, Pages 1541-1559

  Hodgins, Douglas C ^a   Shewen, Patricia E ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

Complement; Maternal antibodies; Neonates; Vaccination

Indexed keywords

BOVINE VIRAL DIARRHEA VACCINE; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C6; COMPLEMENT COMPONENT C7; COMPLEMENT COMPONENT C8; CORTICOSTEROID; CPG OLIGODEOXYNUCLEOTIDE; DNA VACCINE; EPITOPE; GAMMA INTERFERON; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LIVE VACCINE; MATERNAL ANTIBODY; MEASLES VACCINE; PERTUSSIS VACCINE; PHOSPHOROTHIOIC ACID; RETINOL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANTIBODY RESPONSE; B LYMPHOCYTE; BOVINE DIARRHEA VIRUS; BOVINE VIRAL DIARRHEA; CELLULAR IMMUNITY; COLOSTRUM; DENDRITIC CELL; DOMESTIC ANIMAL; ERYTHROCYTE; HUMAN; HYDROCORTISONE BLOOD LEVEL; IMMUNE RESPONSE; IMMUNOREGULATION; MEASLES; MEASLES VACCINATION; NEONATE VACCINATION; NONHUMAN; PASSIVE IMMUNIZATION; PERTUSSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T LYMPHOCYTE; UMBILICAL CORD BLOOD; VACCINATION;

ADRENAL CORTEX HORMONES; ANIMALS; ANIMALS, NEWBORN; B-LYMPHOCYTES; CYTOKINES; HUMANS; IMMUNITY, ACTIVE; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOCOMPETENCE; INFANT, NEWBORN; VACCINATION; VACCINES;

EID: 84856801044     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.12.047     Document Type: Review

References (211)

1. Siegrist C.-A. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine 2003, 21:3406-3412.
2. Wood N., Siegrist C.-A. Neonatal immunization: where do we stand?. Curr Opin Infect Dis 2011, 24:190-195.
3. Adkins B., Leclerc C., Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat Rev Immunol 2004, 4:553-564.
4. Aaby P., Jensen H., Samb B., Cisse B., Sodermann M., Jakobsen M. Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated poliovirus: reanalysis of West African studies. Lancet 2003, 361:2183-2188.
5. Enriquez-Rincon F., Klaus G.G.B. Differing effects of monoclonal anti-hapten antibodies on humoral response to soluble or particulate antigens. Immunology 1984, 52:129-136.
6. Taylor R.B. Regulation of antibody responses by antibody towards the immunogen. Immunol Today 1982, 3:47-51.
7. Getahun A., Heyman B. Studies on the mechanism by which antigen-specific IgG suppresses primary antibody responses: evidence for epitope masking and decreased localization of antigen in the spleen. Scand J Immunol 2009, 70:277-287.
8. Holt P.G., Jones C.A. The development of the immune system during pregnancy and early life. Allergy 2000, 55:688-697.
9. Kovarik J., Siegrist C.-A. Immunity in early life. Immunol Today 1998, 19:150-152.
10. Von Behring E., Wernicke E. Ueber Immunisirung und Heilung von Versuchsthieren bei der Diphtherie. Z Hyg Infektionskr 1892, 12:10-44.
11. Murphy K., Travers P., Walport M. Janeway's immunobiology 2008, Garland Science, New York. 7th ed.
12. Tizard I. Veterinary immunology: an introduction 2008, Saunders, Philadelphia. 8th ed.
13. Hemmings W.A., Morris I.G. An attempt to affect the selective absorption of antibodies from the gut in young mice. Proc R Soc Lond B Biol Sci 1959, 150:403-409.
14. Le Jan C. Cellular components of mammary secretions and neonatal immunity: a review. Vet Res 1996, 27:403-417.
15. Riedel-Caspari G. The antimicrobial and immunomodulating actions of milk leukocytes. Adv Nutr Res 2001, 10:287-307.
16. Tuboly S., Bernáth S., Glávits R., Medveczky I. Intestinal absorption of colostral lymphoid cells in newborn piglets. Vet Immunol Immunopathol 1988, 20:75-85.
17. Tuboly S., Bernáth S., Glávits R., Kovács A., Megyeri Z. Intestinal absorption of colostral lymphocytes in newborn lambs and their role in the development of immune status. Acta Vet Hung 1995, 43:105-115.
18. Reber A.J., Lockwood A., Hippen A.R., Hurley D.J. Colostrum induced phenotypic and trafficking changes in maternal mononuclear cells in a peripheral blood leukocyte model for study of leukocyte transfer to the neonatal calf. Vet Immunol Immunopathol 2006, 109:139-150.
19. Donovan D.C., Reber A.J., Gabbard J.D., Aceves-Avila M., Galland K.L., Holbert K.A., et al. Effect of maternal cells transferred with colostrum on cellular responses to pathogen antigens in neonatal calves. Am J Vet Res 2007, 68:778-782.
20. Bandrick M., Pieters M., Pijoan C., Molitor T.W. Passive transfer of maternal Mycoplasma hyopneumoniae-specific cellular immunity to piglets. Clin Vaccine Immunol 2008, 15:540-543.
21. Osburn B., Stabenfeldt G.H., Ardans A.A., Trees C., Sawyer M. Perinatal immunity in calves. J Am Vet Med Assoc 1974, 164:295-298.
22. Eberhart R.J., Patt J.A. Plasma cortisol concentrations in newborn calves. Am J Vet Res 1971, 32:1921-1927.
23. Massip A., Wouters-Ballman P., Beckers J.F., Ectors F. Development of plasma cortisol in calves from birth to 14 days of age. C R Acad Sci Hebd Seances Acad Sci D 1977, 285:563-565.
24. Liggins G.C. The role of the hypothalamic-pituitary-adrenal axis in preparing the fetus for birth. Am J Obstet Gynecol 2000, 182:475-477.
25. Petraglia F., Imperatore A., Challis J.R. Neuroendocrine mechanisms in pregnancy and parturition. Endocr Rev 2010, 31:783-816.
26. Gitau R., Menson E., Pickles V., Fisk N., Glover V., MacLachlan N. Umbilical cortisol levels as an indicator of the fetal stress response to assisted vaginal delivery. Eur J Obstet Gynecol Reprod Biol 2001, 98:14-17.
27. Parrillo J.E., Fauci A.S. Mechanisms of glucocorticoid action on immune processes. Annu Rev Pharmacool Toxicol 1979, 19:179-201.
28. Chirico G., Gasparoni A., Ciardelli L., Martinotti L., Rondini G. Leukocyte counts in relation to the method of delivery during the first five days of life. Biol Neonate 1999, 75:294-299.
29. Gasparoni A., Maccario R., Chirico G., Belloni C., Mingrat G., De Amici D., et al. Neonatal B lymphocyte subpopulations and method of delivery. Biol Neonate 1992, 61:137-141.
30. Toman M., Faldyna M., Knotigova P., Pokorova D., Sinkora J. Postnatal development of leukocyte subset composition and activity in dogs. Vet Immunol Immunopathol 2002, 87:321-326.
31. Taylor J.A. Leukocyte responses in ruminants. Schalm's veterinary hematology 2000, 391-404. Lippincott, Williams and Wilkins, Philadelphia. 5th ed. B.F. Feldman, J.G. Zinkl, N.C. Jain (Eds.).
32. Duijts L., Bakker-Jonges L.E., Labout J.A.M., Jaddoe V.W.V., Hofman A., Steegers E.A.P. Perinatal stress influences lymphocyte subset counts in neonates. The Generation R Study. Pediatr Res 2008, 63:292-298.
33. Rhen T., Cidlowski J.A. Antiinflammatory action of glucocorticoids - new mechanisms for old drugs. N Engl J Med 2005, 353:1711-1723.
34. Reissland P., Wandinger K.P. Increased cortisol levels in human umbilical cord blood inhibit interferon alpha production of neonates. Immunobiology 1999, 200:227-233.
35. Rook G.A.W. Glucocorticoids and immune function. Baillieres Best Pract Res Clin Endocrinol Metab 1999, 13:567-581.
36. Kovalovsky D., Refojo D., Holsboer F., Arzt E. Molecular mechanisms and Th1/Th2 pathways in corticosteroid regulation of cytokine production. J Neuroimmunol 2000, 109:23-29.
37. Truckenmiller M.E., Bonneau R.H., Norbury C.C. Stress presents a problem for dendritic cells; corticosterone and the fate of MHC class I antigen processing and presentation. Brain Behav Immun 2006, 20:210-218.
38. Yang W.C., Schultz R.D. Effect of corticosteroid on porcine leukocytes: age-related effects of corticosteroid inhibition on porcine lymphocyte responses to mitogens. Vet Immunol Immunopathol 1986, 13:19-29.
39. Bessler H., Mendel C., Straussberg R., Gurary N., Aloni D., Sirota L. Effects of dexamethasone on IL-1 beta, IL-6, and TNF-alpha production by mononuclear cells of newborns and adults. Biol Neonate 1999, 75:225-233.
40. Goldman A.S., Chheda S., Garofalo R., Schmalstieg F.C. Cytokines in human milk: properties and potential effects upon the mammary gland and the neonate. J Mammary Gland Biol Neoplasia 1996, 1:251-258.
41. Bocci V., von Bremen K., Corradeschi F., Franchi F., Luzzi E., Paulesu L. Presence of interferon-gamma and interleukin-6 in colostrum of normal women. Lymphokine Cytokine Res 1993, 12:21-24.
42. Tomicic S., Johansson G., Voor T., Björkstén B., Böttcher M.F., Jenmalm M.C. Breast milk cytokine and IgA composition differ in Estonian and Swedish mothers - relationship to microbial pressure and infant allergy. Pediatr Res 2010, 68:330-334.
43. Malamitsi-Puchner A., Protonotariou E., Boutsikou T., Makrakis E., Sarandakou A., Creatsas G. The influence of the mode of delivery on circulating cytokine concentrations in the perinatal period. Early Hum Dev 2005, 81:387-392.
44. Ogawa J., Sasahara A., Yoshida T., Sira M.M., Futatani T., Kanegane H., et al. Role of transforming growth factor-beta in breast milk for initiation of IgA production in newborn infants. Early Hum Dev 2004, 77:67-75.
45. Yamanaka H., Hagiwara K., Kirisawa R., Iwai H. Transient detection of proinflammatory cytokines in sera of colostrum - fed newborn calves. J Vet Med Sci 2003, 65:813-816.
46. Nguyen T.V., Yuan L., Azevedo M.S.P., Jeong K.-I., Gonzalez A.-M., Saif L. Transfer of maternal cytokines to suckling piglets: in vivo and in vitro models with implications for immunomodulation of neonatal immunity. Vet Immunol Immunopathol 2007, 117:236-248.
47. Garofalo R., Chheda S., Mei F., Palkowetz K.H., Rudloff H.E., Schmalsteig F.C., et al. Interleukin-10 in human milk. Pediatr Res 1995, 37:444-449.
48. Firth M.A., Shewen P.E., Hodgins D.C. Passive and active components of neonatal innate immune defenses. Anim Health Res Rev 2005, 6:143-158.
49. Taylor P.W. Resistance of bacteria to complement. Virulence mechanisms of bacterial pathogens 1995, 49-64. American Society for Microbiology Press, Washington DC. 2nd ed. J.A. Roth (Ed.).
50. Zach T.L., Hostetter M.K. Biochemical abnormalities of the third component of complement in neonates. Pediatr Res 1989, 26:116-120.
51. Dempsey P.W., Allison M.E., Akkaraju S., Goodnow C.C., Fearon D.T. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 1996, 271:348-350.
52. Pihlgren M., Fulurija A., Villiers M.B., Tougne C., Lambert P.-H., Villiers C.L., et al. Influence of complement C3 amount on IgG responses in early life: immunization with C3b-conjugated antigen increases murine neonatal antibody responses. Vaccine 2004, 23:329-335.
53. Durandy A., De Saint Basile G., Lisowska-Grospierre B., Gauchat J.F., Forveille M., Kroczek R.A., et al. Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborns. J Immunol 1995, 154:1560-1568.
54. Petty R.E., Hunt D.W.C. Neonatal dendritic cells. Vaccine 1998, 16:1378-1382.
55. De Wit D., Olislagers V., Goriely S., Vermeulen F., Wagner H., Goldman M. Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns. Blood 2004, 103:1030-1032.
56. Belnoue E., Pihlgren M., McGaha T.L., Tougne C., Rochat A.-F., Bossen C., et al. APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells. Blood 2008, 111:2755-2764.
57. Pihlgren M., Friedli M., Tougne C., Rochat A.F., Lambert P.-H., Siegrist C.-A. Reduced ability of neonatal and early-life bone marrow stromal cells to support plasmablast survival. J Immunol 2006, 176:165-172.
58. Pihlgren M., Tougne C., Bozzotti P., Fulurija A., Duchosal M.A., Lambert P.-H., et al. Unresponsiveness to lymphoid-mediated signals at the neonatal follicular dendritic cell precursor level contributes to delayed germinal center induction and limitations of neonatal antibody responses to T-dependent antigens. J Immunol 2003, 170:2824-2832.
59. Boyd N.K., Cohen N.D., Lim W.S., Martens R.J., Chaffin M.K., Ball J.M. Temporal changes in cytokine expression of foals during the first month of life. Vet Immunol Immunopathol 2003, 92:75-85.
60. Barrios C., Brawand P., Berney M., Brandt C., Lambert P.-H., Siegrist C.-A. Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2-biased pattern which persists after adult boosting. Eur J Immunol 1996, 26:1489-1496.
61. Adkins B., Bu Y., Cepero E., Perez R. Exclusive Th2 primary effector function in spleens but mixed Th1/Th2 function in lymph nodes of murine neonates. J Immunol 2000, 164:2347-2353.
62. + cells. Eur J Immunol 1992, 22:329-334.
63. Splawski J.B., Jelinek D.F., Lipsky P.E. Delineation of the functional capacity of human neonatal lymphocytes. J Clin Invest 1991, 87:545-553.
64. Splawski J.B., Nishioka J., Nishioka Y., Lipsky P.E. CD40 ligand is expressed and functional on activated neonatal T cells. J Immunol 1996, 156:119-127.
65. Harris D.T., Schumacher M.J., Locascio J., Besencon F.J., Olson G.B., DeLuca D., et al. Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc Natl Acad Sci USA 1992, 89:10006-10010.
66. Balogh P., Aydar Y., Tew J., Szakal A.K. Ontogeny of the follicular dendritic cell phenotype and function in the postnatal murine spleen. Cell Immunol 2001, 214:45-53.
67. Chattha K.S., Firth M.A., Hodgins D.C., Shewen P.E. Expression of complement receptor 2 (CD21), membrane IgM and the inhibitory receptor CD32 (FcγRIIB) in the lymphoid tissues of neonatal calves. Vet Immunol Immunopathol 2010, 137:99-108.
68. Tedder T.F., Clement L.T., Cooper M.D. Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody. J Immunol 1984, 133:678-683.
69. Macardle P.J., Weedon H., Fusco M., Nobbs S., Ridings J., Flego L., et al. The antigen receptor complex on cord B lymphocytes. Immunology 1997, 90:376-382.
70. Tasker L., Marshall-Clarke S. Functional responses of human neonatal B lymphocytes to antigen receptor cross-linking and CpG DNA. Clin Exp Immunol 2003, 134:409-419.
71. Jeklova E., Leva L., Knotigova P., Faldyna M. Age-related changes in selected haematology parameters in rabbits. Res Vet Sci 2009, 86:525-528.
72. Juul-Madsen H.R., Jensen K.H., Nielsen J., Damgaard B.M. Ontogeny and characterization of blood leukocyte subsets and serum proteins in piglets before and after weaning. Vet Immunol Immunopathol 2010, 133:95-108.
73. Chattha K.S., Firth M.A., Hodgins D.C., Shewen P.E. Variation in expression of membrane IgM, CD21 (CR2), CD32 (Fc gamma RIIB) on bovine lymphocytes with age: a longitudinal study. Dev Comp Immunol 2010, 24:510-517.
74. Sellon R.K., Levy J.K., Jordan H.L., Gebhard D.H., Tompkins M.B., Tompkins W.A. Changes in lymphocyte subsets with age in perinatal cats: late gestation through eight weeks. Vet Immunol Immunopathol 1996, 53:105-113.
75. Faldyna M., Levá L., Knötigová P., Toman M. Lymphocyte subsets in peripheral blood of dogs - a flow cytometric study. Vet Immunol Immunopathol 2001, 82:23-37.
76. Erkeller-Yuksel F.M., Deneys V., Yuksel B., Hannet I., Hulstaert F., Hamilton C., et al. Age-related changes in human blood lymphocyte subpopulations. J Pediatr 1992, 120:216-222.
77. de Vries E., de Bruin-Versteeg S., Comans-Bitter W.M., de Groot R., Hop W.C., Boerma G.J., et al. Longitudinal survey of lymphocyte subpopulations in the first year of life. Pediatr Res 2000, 47:528-537.
78. D'Arena G., Musto P., Cascavilla N., Di Giorgio G., Fusilla S., Zendoli F., et al. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features. Haematologica 1998, 83:197-203.
79. Kampen A.H., Olsen I., Tollersrud T., Storset A.K., Lund A. Lymphocyte subpopulations and neutrophil function in calves during the first 6 months of life. Vet Immunol Immunopathol 2006, 113:53-63.
80. Young A.J., Marston W.L., Dessing M., Dudler L., Hein W.R. Distinct recirculating and non-recirculating B-lymphocyte pools in the peripheral blood are defined by coordinated expression of CD21 and L-selectin. Blood 1997, 90:4865-4875.
81. Young A.J., Dudler L., Yamaguchi K., Marston W., Hein W.R. Structure and expression of ovine complement receptor type 2. Vet Immunol Immunopathol 1999, 72:67-72.
82. Young A.J., Dudler L., Marston W.L. An enhanced role for the recirculating lymphocyte in the neonatal immune system. Dev Comp Immunol 2000, 24:691-701.
83. Thornton C.A., Holloway J.A., Warner J.O. Expression of CD21 and CD23 during human fetal development. Pediatr Res 2002, 52:245-250.
84. Butler J.E., Sun J., Weber P., Navarro P., Francis D. Antibody repertoire development in fetal and newborn piglets. III. Colonization of the gastrointestinal tract selectively diversifies the preimmune repertoire in mucosal lymphoid tissues. Immunology 2000, 100:119-130.
85. Butler J.E., Weber P., Sinkora M., Baker D., Schoenherr A., Mayer B., et al. Antibody repertoire development in fetal and newborn piglets. VIII. Colonization is required for newborn piglets to make serum antibodies to T-dependent and type 2 T-independent antigens. J Immunol 2002, 169:6822-6830.
86. Butler J.E., Francis D., Freeling J., Weber P., Krieg A.M. Antibody repertoire development in fetal and newborn piglets. IX. Three pathogen-associated molecular patterns act synergistically to allow germfree piglets to respond to type 2 thymus-independent and thymus-dependent antigens. J Immunol 2005, 175:6772-6785.
87. Butler J.E., Lager K.M., Splichal I., Francis D., Kacskovics I., Sinkora M., et al. The piglet as a model for B cell and immune system development. Vet Immunol Immunopathol 2009, 128:147-170.
88. Siegrist C.-A. Neonatal and early life vaccinology. Vaccine 2001, 19:3331-3346.
89. Martin Du Pan R. The vaccination of the newborn infant against pertussis. J Pediatr 1958, 53:180-186.
90. Roduit C., Bozzotti P., Mielcarek N., Lambert P.-H., Del Guidice G., Locht C., et al. Immunogenicity and protective efficacy of neonatal vaccination against Bordetella pertussis in a murine model: evidence for early control of pertussis. Infect Immun 2002, 70:3521-3528.
91. Burstyn D.G., Baraff L.J., Peppler M.S., Leake R.D., St Geme J., Manclark C.R. Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis. Infect Immun 1983, 41:1150-1156.
92. Van Savage J., Decker M.D., Edwards K.M., Sell S.H., Karzon D.T. Natural history of pertussis antibody in the infant and effect on vaccine response. J Infect Dis 1990, 161:487-492.
93. Belloni C., De Silvestri A., Tinelli C., Avanzini M.A., Marconi M., Strano F., et al. Immunogenicity of a three-component acellular pertussis vaccine administered at birth. Pediatrics 2003, 111:1042-1045.
94. Knuf M., Schmitt H.-J., Wolter J., Schuerman L., Jacquet J.-M., KieningerD., et al. Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants. J Pediatr 2008, 152:655-660.
95. Wood N., McIntyre P., Marshall H., Roberton D. Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age. Pediatr Infect Dis J 2010, 29:209-215.
96. Englund J.A., Anderson E.L., Reed G.F., Decker M.D., Edwards K.M., Pichichero M.E., et al. The effect of maternal antibody on the serological response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids. Pediatrics 1995, 96:580-584.
97. Siegrist C.-A. Blame vaccine interference, not neonatal immunization, for suboptimal responses after neonatal diphtheria, tetanus, and acellular pertussis immunization. J Pediatr 2008, 153:305-307.
98. Ellis J., West K., Cortese V., Konoby C., Weigel D. Effect of maternal antibodies on induction and persistence of vaccine-induced immune responses against bovine viral diarrhea virus type II in young calves. J Am Vet Med Assoc 2001, 219:351-356.
99. Brar J.S., Johnson D.W., Muscoplat C.C., Shope R.E., Meiske J.C. Maternal immunity to infectious bovine rhinotracheitis and bovine viral diarrhea viruses: duration and effect on vaccination in young calves. Am J Vet Res 1978, 39:241-244.
100. Platt R., Widel P.W., Kesl L.D., Roth J.A. Comparison of the humoral and cellular immune responses to a pentavalent modified live virus vaccine in three age groups of calves with maternal antibodies, before and after BVDV type 2 challenge. Vaccine 2009, 27:4508-4519.
101. Gans H., DeHovitz R., Forghani B., Beeler J., Maldonado Y., Arvin A.M. Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life. Vaccine 2003, 21:3398-3405.
102. Rijkers G.T., Sanders E.A., Breukels M.A., Zegers B.J. Infant B cell responses to polysaccharide determinants. Vaccine 1998, 16:1396-1400.
103. Hodgins D.C., Shewen P.E. Vaccination of neonatal colostrum-deprived calves against Pasteurella haemolytica A1. Can J Vet Res 2000, 64:3-8.
104. Confer A.W., Simons K.R., Panciera R.J., Mort A.J., Mosier D.A. Serum antibody response to carbohydrate antigens of Pasteurella haemolytica serotype 1: relation to experimentally induced bovine pneumonic pasteurellosis. Am J Vet Res 1989, 50:98-105.
105. Wilson S.M., Wilkie B.N. B-1 and B-2 B-cells in the pig cannot be differentiated by expression of CD5. Vet Immunol Immunopathol 2007, 115:10-16.
106. Chevallier N., Berthelemy M., Lainé V., Le Rhun D., Féménia F., Polack B., et al. B-1-like cells exist in sheep. Characterization of their phenotype and behaviour. Immunology 1998, 95:178-184.
107. Gagro A., McCloskey N., Challa A., Holder M., Grafton G., Pound F.D., et al. CD5-positive and CD5-negative human B cells converge to an indistinguishable population on signalling through B-cell receptors and CD40. Immunology 2000, 101:201-209.
108. Ferguson A.R., Youd M.E., Corley R.B. Marginal zone B cells transport and deposit IgM-containing immune complexes onto follicular dendritic cells. Int Immunol 2004, 16:1411-1422.
109. Timens W., Boes A., Rozeboom-Uiterwijk T., Poppema S. Immaturity of the human splenic marginal zone in infancy. Possible contribution to the deficient infant immune response. J Immunol 1989, 143:3200-3206.
110. Trotter C.L., McVernon J., Ramsay M.E., Whitney C.G., Mulholland E.K., Goldblatt D., et al. Optimizing the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae. Vaccine 2008, 26:4434-4445.
111. Dagan R., Poolman J., Siegrist C.-A. Glycoconjugate vaccines and immune interference: a review. Vaccine 2010, 28:5513-5523.
112. Bodger M.P., Janossy G., Bollum F.J., Burford D.G., Hoffbrand A.V. The ontogeny of terminal deoxynucleotidyl transferase positive cells in the human fetus. Blood 1983, 61:1125-1131.
113. Sinkora M., Sinkorova J., Butler J.E. B cell development and VDJ rearrangement in the fetal pig. Vet Immunol Immunopathol 2002, 87:341-346.
114. Rothenberg E., Triglia D. Clonal proliferation unlinked to terminal deoxynucleotidyl transferase synthesis in thymocytes of young mice. J Immunol 1983, 130:1627-1633.
115. Friedberg S.H., Weissman I.L. Lymphoid tissue architecture. II. Ontogeny of peripheral T and B cells in mice: evidence against Peyer's patches as the site of generation of B cells. J Immunol 1974, 113:1477-1492.
116. Timens W., Rozeboom T., Poppema S. Fetal and neonatal development of human spleen: an immunohistological study. Immunology 1987, 60:603-609.
117. Chattha K.S., Hodgins D.C., DeLay J., Antoine N., Shewen P.E. Immunohistochemical investigation of cells expressing CD21, membrane IgM, CD32 and a follicular dendritic cell marker in the lymphoid tissues of neonatal calves. Vet Immunol Immunopathol 2010, 137:284-290.
118. Ryan M., Gothefors L., Storsaeter L., Mills K.H. Bordetella pertussis-specific Th1/Th2 cells generated following respiratory infection or immunization with an acellular vaccine: comparison of the T cell cytokine profiles in infants and mice. Dev Biol Stand 1997, 89:297-305.
119. 2+ mobilization in FcγR-transfected human B cells. Int Immunol 1998, 10:141-146.
120. Sármay G., Rozsnyay Z., Koncz G., Danilkovich A., Gergely J. The alternative splicing of human Fc gamma RII mRNA is regulated by activation of B cells with mIgM cross-linking, interleukin-4, or phorbolester. Eur J Immunol 1995, 25:262-268.
121. Van den Herik-Oudijk I.E., Westerdaal N.A.C., Henriquez N.V., Capel P.J.A., Van de Winkel J.G.J. Functional analysis of human FcγRII (CD32) isoforms expressed in B lymphocytes. J Immunol 1994, 152:574-585.
122. Firth M.A., Chattha K.S., Hodgins D.C., Shewen P.E. Multiple bovine FcgammaRIIb sub-isoforms generated by alternative splicing. Vet Immunol Immunopathol 2010, 135:43-51.
123. Turnberg D., Botto M. The regulation of the complement system: insights from genetically-engineered mice. Mol Immunol 2003, 40:145-153.
124. Ishikawa H., Kanamori Y., Hamada H., Kiyono H. Development and function of organized gut-associated lymphoid tissues. Mucosal immunology 2005, Elsevier, Amsterdam. 3rd ed. J. Mestecky, J. Bienenstock, M.E. Lamm, L. Mayer, J.R. McGhee, W. Strober (Eds.).
125. Reynolds J.D., Morris B. The evolution and involution of Peyer's patches in fetal and postnatal sheep. Eur J Immunol 1983, 13:627-635.
126. Parreño V., Hodgins D.C., de Arriba L., Kang S.Y., Yuan L., Ward L.A., et al. Serum and intestinal isotype antibody responses to Wa human rotavirus in gnotobiotic pigs are modulated by maternal antibodies. J Gen Virol 1999, 80:1417-1428.
127. Manak R.C. Neonatal calf serum immunoregulation of lymphocyte blastogenic responses. J Anim Sci 1986, 62:759-771.
128. Bogunia-Kubik K., Natarajan P., Brown S., Wolley J., Alcocer M., Fallen P.R., et al. Cord blood serum affects T cells ability to produce and respond to IL-2. Cytokine 2003, 22:42-49.
129. Smith T. Active immunity produced by so-called balanced or neutral mixtures of diphtheria toxin and antitoxin. J Exp Med 1909, 11:241-256.
130. Glenny A.T., Südmersen H.J. Notes on the production of immunity to diphtheria toxin. J Hyg (Lond) 1921, 20:176-220.
131. Henry C., Jerne N.K. Competition of 19S and 7S antigen receptors in the regulation of the primary immune response. J Exp Med 1968, 128:133-152.
132. Branch D.R., Scofield T.L., Moulds J.J., Swanson J.L. Unexpected suppression of anti-Fy(a) and prevention of hemolytic disease of the fetus and newborn after administration of Rh immune globulin. Transfusion (Paris) 2011, 51:816-819.
133. Brinc D., Le-Tien H., Crow A.R., Siragam V., Freedman J., Lazarus A.H. Immunoglobulin G-mediated regulation of the murine immune response to transfused red blood cells occurs in the absence of active immune suppression: implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the fetus and newborn. Immunology 2008, 124:141-146.
134. Brinc D., Lazarus A.H. Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn. Hematol Am Soc Hematol Educ Program 2009, 185-191.
135. Kumpel B.M., Elson C.J. Mechanism of anti-D-mediated immune suppression - a paradox awaiting resolution. Trends Immunol 2001, 22:26-31.
136. Wiersma E.J., Coulie P.G., Heyman B. Dual immunoregulatory effects of monoclonal IgG-antibodies: suppression and enhancement of the antibody response. Scand J Immunol 1989, 29:439-448.
137. Heyman B. Regulation of antibody responses via antibodies, complement, and Fc receptors. Annu Rev Immunol 2000, 18:709-737.
138. Hjelm F., Carlsson F., Getahun A., Heyman B. Antibody-mediated regulation of the immune response. Scand J Immunol 2006, 64:177-184.
139. Chappuis G. Neonatal immunity and immunisation in early age: lessons from veterinary medicine. Vaccine 1998, 16:1468-1472.
140. Griffin D.E. Measles virus-induced suppression of immune responses. Immunol Rev 2010, 236:176-189.
141. Hansen T.H., Bouvier M. MHC class I antigen presentation: learning from viral evasion strategies. Nat Rev Immunol 2009, 9:503-513.
142. McInerney G.M. Karlsson Hedestam GB. Direct cleavage, proteasomal degradation and sequestration: three mechanisms of viral subversion of Type I interferon responses. J Innate Immun 2009, 1:599-606.
143. Sellin C.I., Horvat B. Current animal models: transgenic animal models for the study of measles pathogenesis. Curr Top Microbiol Immunol 2009, 330:111-127.
144. Besser T.E., McGuire T.C., Gay C.C., Pritchett L.C. Transfer of functional immunoglobulin G (IgG) antibody into the gastrointestinal tract accounts for IgG clearance in calves. J Virol 1988, 62:2234-2237.
145. Ward L.A., Rich E.D., Besser T.E. Role of maternally derived circulating antibodies in protection of neonatal swine against porcine group A rotavirus. J Infect Dis 1996, 174:276-282.
146. Besser T.E., Gay C.C., McGuire T.C., Evermann J.F. Passive immunity to bovine rotavirus infection associated with transfer of serum antibody into the intestinal lumen. J Virol 1988, 62:2238-2242.
147. Minskoff S.A., Matter K., Mellman I. Fc gamma RII-B1 regulates the presentation of B cell receptor-bound antigens. J Immunol 1998, 161:2079-2083.
148. Barclay A.N. The leukocyte antigen facts book 1997, Academic Press, San Diego, p. 209-12. 2nd ed.
149. Macardle P.J., Mardell C., Bailey S., Wheatland L., Ho A., Jessop C., et al. FcγRIIB expression on human germinal center B lymphocytes. Eur J Immunol 2002, 32:3736-3744.
150. Amigorena S., Bonnerot C., Drake J.R., Choquet D., Hunziker W., Guillet J.G., et al. Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes. Science 1992, 256:1808-1812.
151. Miettinen H.M., Matter K., Hunziker W., Rose J.K., Mellman I. Fc receptor endocytosis is controlled by a cytoplasmic domain determinant that actively prevents coated pit localization. J Cell Biol 1992, 116:875-888.
152. Antoniou A., Watts C. Antibody modulation of antigen presentation: positive and negative effects on presentation of the tetanus toxin antigen via the murine B cell isoform of FcγRII. Eur J Immunol 2002, 32:530-540.
153. Sármay G., Koncz G., Gergely J. Integration of activatory and inhibitory signals in human B cells. Immunol Lett 1996, 54:93-100.
154. Griffioen A.W., Franklin S.W., Zegers B.J., Rijkers G.T. Expression and functional characteristics of the complement receptor type 2 on adult and neonatal B lymphocytes. Clin Immunol Immunopathol 1993, 69:1-8.
155. Rudge E.U., Cutler A.J., Pritchard N.R., Smith K.G.C. Interleukin 4 reduces expression of inhibitory receptors on B cells and abolishes CD22 and FcγRII-mediated B cell suppression. J Exp Med 2002, 195:1079-1085.
156. Stein S.H., Phipps R.P. Elevated levels of intracellular cAMP sensitize resting B lymphocytes to immune complex-induced unresponsiveness. Eur J Immunol 1991, 21:313-318.
157. Phillips N.E., Gravel K.A., Tumas K., Parker D.C. IL-4 (B cell stimulatory factor 1) overcomes Fc gamma receptor-mediated inhibition of mouse B lymphocyte proliferation without affecting inhibition of c-myc mRNA induction. J Immunol 1988, 141:4243-4249.
158. Mongini P.K.A., Inman J.K. Cytokine dependency of human B cell cycle progression elicited by ligands which coengage BCR and the CD21/CD19/CD81 costimulatory complex. Cell Immunol 2001, 207:127-140.
159. Wernersson S., Karlsson M.C.I., Dahlström J., Mattsson R., Verbeek J.S., Heyman B. IgG-mediated enhancement of antibody responses is low in Fc receptor γ chain-deficient mice and increased in FcγRII-deficient mice. J Immunol 1999, 163:618-622.
160. Díaz de Ståhl T., Dahlström J., Carroll M.C., Heyman B. A role for complement in feedback enhancement of antibody responses by IgG3. J Exp Med 2003, 197:1183-1190.
161. Heyman B. In vivo enhancement of the specific antibody response via the low-affinity receptor for IgE. Eur J Immunol 1993, 23:1739-1742.
162. Westman S., Gustavsson S., Heyman B. Early expansion of secondary B cells after primary immunization with antigen complexed with IgE. Scand J Immunol 1997, 46:10-15.
163. Getahun A., Heyman B. How antibodies act as natural adjuvants. Immunol Lett 2006, 104:38-45.
164. Boruchov A.M., Heller G., Veri M.-C., Bonvini E., Ravetch J.V., Young J.W. Activating and inhibitory IgG Fc receptors on human DCs mediate opposing functions. J Clin Invest 2005, 115:2914-2923.
165. Yada A., Ebihara S., Matsumura K., Endo S., Maeda T., Nakamura A., et al. Accelerated antigen presentation and elicitation of humoral response in vivo by FcγRIIB- and FcγRI/III-mediated immune complex uptake. Cell Immunol 2003, 225:21-32.
166. Bajtay Z., Csomor E., Sándor N., Erdei A. Expression and role of Fc- and complement-receptors on human dendritic cells. Immunol Lett 2006, 46-52.
167. Zhu X., Meng G., Dickinson B.L., Li X., Mizoguchi E., Miao L., et al. MHC class I-related neonatal Fc receptor for IgG is functionally expressed in monocytes, intestinal macrophages, and dendritic cells. J Immunol 2001, 166:3266-3276.
168. Li K., Fazekasova H., Wang N., Sagoo P., Peng W., Khamri W., et al. Expression of complement components, receptors and regulators by human dendritic cells. Mol Immunol 2011, 48:1121-1127.
169. Gerber J.S., Mosser D.M. Stimulatory and inhibitory signals originating from the macrophage Fcγ receptors. Microbes Infect 2001, 3:131-139.
170. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J Exp Med 1994, 179:1109-1118.
171. Bergtold A., Desai D.D., Gavhane A., Clynes R. Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. Immunity 2005, 23:503-514.
172. Qiao S.-W., Kobayashi K., Johansen F.-E., Sollid L.M., Andersen J.T., Milford E., et al. Dependence of antibody-mediated presentation of antigen on FcRn. Proc Natl Acad Sci USA 2008, 105:9337-9342.
173. Regnault A., Lankar D., Lacabanne V., Rodriguez A., Théry C., Rescigno M., et al. Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med 1999, 189:371-380.
174. + CTL responses in vivo. J Immunol 2002, 168:2240-2246.
175. + dendritic cells. Proc Natl Acad Sci USA 2011, 108:9927-9932.
176. Manca F., Fenoglio D., Li Pira G., Kunkl A., Celada F. Effect of antigen/antibody ratio on macrophage uptake, processing, and presentation to T cells of antigen complexed with polyclonal antibodies. J Exp Med 1991, 173:37-48.
177. Davidson H.W., Watts C. Epitope-directed processing of specific antigen by B lymphocytes. J Cell Biol 1989, 109:85-92.
178. Watts C., Antoniou A., Manoury B., Hewitt E.W., Mckay L.M., Grayson L., et al. Modulation by epitope-specific antibodies of class II MHC-restricted presentation of the tetanus toxin antigen. Immunol Rev 1998, 164:11-16.
179. Ohishi K., Kanoh M., Shinomiya H., Hitsumoto Y., Utsumi S. Complement activation by cross-linked B cell-membrane IgM. J Immunol 1995, 154:3173-3179.
180. Rossbacher J., Shlomchik M.J. The B cell receptor itself can activate complement to provide the complement receptor1/2 ligand required to enhance B cell immune responses in vivo. J Exp Med 2003, 198:591-602.
181. Rossbacher J., Haberman A.M., Neschen S., Khalil A., Shlomchik M.J. Antibody independent B cell-intrinsic and -extrinsic roles for CD21/35. Eur J Immunol 2006, 36:2384-2393.
182. Thornton B.P., Vetvicka V., Ross G.D. Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes. J Immunol 1994, 152:1727-1737.
183. Thornton B.P., Vetvicka V., Ross G.D. Function of C3 in a humoral response: iC3b/C3dg bound to an immune complex generated with natural antibody and a primary antigen promotes antigen uptake and the expression of co-stimulatory molecules by all B cells, but only stimulates immunoglobulin synthesis by antigen-specific B cells. Clin Exp Immunol 1996, 104:531-537.
184. Boackle S.A., Morris M.A., Holers V.M., Karp D.R. Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells. J Immunol 1998, 162:6537-6543.
185. Santoro L., Drouet C., Reboul A., Mach J.-P., Colomb M.G. Covalent binding of C3b to monoclonal antibodies selectively up-regulates heavy chain epitope recognition by T cells. Eur J Immunol 1994, 24:1620-1626.
186. Santoro L., Reboul A., Kerblat I., Drouet C., Colomb M.G. Monoclonal IgG as antigens: reduction is an early intracellular event of their processing by antigen-presenting cells. Int Immunol 1996, 8:211-219.
187. Baiu D.C., Prechl J., Tchorbanov A., Molina H.D., Erdei A., Sulica A., et al. Modulation of the humoral immune response by antibody-mediated antigen targeting to complement receptors and Fc receptors. J Immunol 1999, 162:3125-3130.
188. Prechl J., Baiu D.C., Horváth A., Erdei A. Modeling the presentation of C3d-coated antigen by B lymphocytes: enhancement by CR1/2-BCR co-ligation is selective for the co-ligating antigen. Int Immunol 2002, 14:241-247.
189. Molnár E., Erdei A., Prechl J. Novel roles for murine complement receptors type 1 and 2. I. Regulation of B cell survival and proliferation by CR1/2. Immunol Lett 2008, 116:156-162.
190. Phan T.G., Grigorova I., Okada T., Cyster J.G. Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells. Nat Immunol 2007, 8:992-1000.
191. Whipple E.C., Shanahan R.S., Ditto A.H., Taylor R.P., Lindorfer M.A. Analyses of the in vivo trafficking of stoichiometric doses of an anti-complement receptor 1/2 monoclonal antibody infused intravenously in mice. J Immunol 2004, 173:2297-2306.
192. Qin D., Wu J., Vora K.A., Ravetch J.V., Szakal A.K., Manser T., et al. Fc gamma receptor IIB on follicular dendritic cells regulates the B cell recall response. J Immunol 2000, 164:6268-6275.
193. Griebel P.J. Mucosal vaccination of the newborn: an unrealized opportunity. Expert Rev Vaccines 2009, 8:1-3.
194. Sharma J.M., Zhang Y., Jensen D., Rautenschlein S., Yeh H.Y. Field trial in commercial broilers with a multivalent in ovo vaccine comprising a mixture of live viral vaccines against Marek's disease, infectious bursal disease, Newcastle disease, and fowl pox. Avian Dis 2002, 46:613-622.
195. Ahmad J., Sharma J.M. Evaluation of a modified-live virus vaccine administered in ovo to protect chickens against Newcastle disease. Am J Vet Res 1992, 53:1999-2004.
196. Welborn L.V., DeVries J.G., Ford R., Franklin R.T., Hurley K.F., McClure K.D., et al. 2011 AAHA canine vaccination guidelines. JAAHA 2011, 47:1-42.
197. Goddard A., Leisewitz A.L. Canine parvovirus. Vet Clin Small Anim 2010, 40:1041-1053.
198. Borràs E., Urbiztondo L., Costa J., Batalla J., Torner N., Plasencia A., et al. Measles antibodies and response to vaccination in children aged less than 14 months: implications for age of vaccination. Epidemiol Infect 2011, 11:1-8.
199. Xue W., Ellis J., Mattick D., Smith L., Brady R., Trigo E. Immunogenicity of a modified-live virus against bovine viral diarrhea virus types 1 and 2, infectious bovine rhinotracheitis virus, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus when administered intranasally in young calves. Vaccine 2010, 14:3784-3792.
200. Weiblen R., Woods G.T., Mansfield M.E., Crandell R.A. Comparative study of vaccines in preventing respiratory disease in beef calves after weaning. Res Commun Chem Pathol Pharmacol 1982, 35:303-324.
201. Van Binnendijk R.S., Poelen M.C.M., van Amerongen G., de Vries P., Osterhaus A.D.M.E. Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies. J Infect Dis 1997, 175:524-532.
202. Siegrist C.-A., Córdova M., Brandt C., Barrios C., Berney M., Tougne C., et al. Determinants of infant responses to vaccines in presence of maternal antibodies. Vaccine 1998, 16:1409-1414.
203. Sabin A.B., Arechiga A.F., de Castro J.F., Sever J.L., Madden D.L., Shekarchi I., et al. Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. I. Different results with undiluted human diploid cell and chick embryo fibroblast vaccines. JAMA 1983, 249:2651-2662.
204. Sabin A.B., Arechiga A.F., de Castro J.F., Albrecht P., Sever J.L., Shekarchi I. Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. II. Vaccine comparisons and evidence for multiple antibody response. JAMA 1984, 251:2363-2371.
205. Wong-Chew R.M., García-León M.L., Torrija B.E-T., Hernández-Pérez B., Cardiel-Marmolejo L.E., Beeler J.A., et al. Increasing the time exposure to aerosol measles vaccine elicits an immune response equivalent to that seen in 9-month-old Mexican children given the same dose subcutaneously. J Infect Dis 2011, 204:426-432.
206. Monteil M., Le Potier M.F., Cariolet R., Houdayer C., Eliot M. Effective priming of neonates born to immune dams against the immunogenic pseudorabies virus glycoprotein gD by replication-incompetent adenovirus-mediated gene transfer at birth. J Gen Virol 1997, 78:3303-3310.
207. Van Drunen Littel-Van Den Hurk S., Braun R.P., Lewis P.J., Karvonen B.C., Babiuk L.A., Griebel P.J. Immunization of neonates with DNA encoding a bovine herpesvirus glycoprotein is effective in the presence of maternal antibodies. Viral Immunol 1999, 12:67-77.
208. Zhang L., Tian X., Zhou F. Intranasal administration of CpG oligonucleotides induces mucosal and systemic Type 1 immune responses and adjuvant activity to porcine reproductive and respiratory syndrome killed virus vaccine in piglets in vivo. Int Immunopharmacol 2007, 15:1732-1740.
209. Mutwiri G., van Drunen Littel-van den Hurk S., Babiuk L.A. Approaches to enhancing immune responses stimulated by CpG oligonucleotides. Adv Drug Deliv Rev 2009, 61:226-232.
210. Ross A.C., Chen Q., Ma Y. Augmentation of antibody responses by retinoic acid and costimulatory molecules. Semin Immunol 2009, 21:42-50.
211. Yuan L., Geyer A., Hodgins D.C., Fan Z., Qian Y., Chang K.-O., et al. Intranasal administration of 2/6-rotavirus-like particles with mutant Escherichia coli heat-labile toxin (LT-R192G) induces antibody-secreting cell responses but not protective immunity in gnotobiotic pigs. J Virol 2000, 74:8843-8853.